Gilead Sciences (United Kingdom)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
253
Total Open
Publications
181
Total
Citations
5.6K
Open Access
Percentage
72%
Total
Publications
253
Total Open
Publications
181
Total
Citations
5.6K
Breakdown
Publisher Open
32%
Both
34%
Other Platform Open
5%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
65
Hybrid 39%
65
No Guarantees 21%
35
Other Platform Open
Domain 86%
83
Institution 34%
33
Other Internet 7%
7
Preprint 2%
2
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 85 |
DOI | Other Internet | 6 |
University of Milano-Bicocca - BOA | Institution | 4 |
RISalud Institutional Health Repository of Andalucía | Institution | 3 |
ORA - Oxford University Research Archive | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Imperial College London - Spiral | Institution | 3 |
Unknown Repository | Other Internet | 2 |
University of Udine - Institutional Research Information System | Institution | 2 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |